1. Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China. Issue 11 (26th November 2020) Authors: Liu, Qiao; Luo, Xia; Peng, Liubao; Yi, Lidan; Wan, Xiaomin; Zeng, Xiaohui; Tan, Chongqing Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China. Issue 11 (26th November 2020) Authors: Liu, Qiao; Luo, Xia; Peng, Liubao; Yi, Lidan; Wan, Xiaomin; Zeng, Xiaohui; Tan, Chongqing Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA. Issue 12 (11th December 2019) Authors: Zeng, Xiaohui; Wan, Xiaomin; Peng, Liubao; Peng, Ye; Ma, Fang; Liu, Qiao; Tan, Chongqing Journal: BMJ open Issue: Volume 9:Issue 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ordering kinetics of lamella-forming block copolymers under the guidance of various external fields studied by dynamic self-consistent field theory. Issue 9 (17th February 2017) Authors: Wan, Xiaomin; Gao, Tong; Zhang, Liangshun; Lin, Jiaping Journal: Physical chemistry chemical physics Issue: Volume 19:Issue 9(2017) Page Start: 6707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗